Ocrelizumab Monoclonal Antibody Drug. Targets CD20 On B-cells And Is Used In The Treatment Multiple Sclerosis. Generic Name And. Royalty-Free Stock Photo
Ocrelizumab monoclonal antibody drug. Targets CD20 on B-cells and is used in the treatment multiple sclerosis. Generic name and. #186814971
Description
Ocrelizumab monoclonal antibody drug. Targets CD20 on B-cells and is used in the treatment multiple sclerosis. Generic name and stylized antibody representation